Atopic Dermatitis Digital Highlights Hub

This course will provide you with valuable updates in Atopic Dermatitis (AD) presented at the 28th Masters of Pediatric Dermatology and the 18th Annual South Beach Symposium from high caliber Dermatology physicians below:

  • Pathogenesis of Atopic Dermatitis and Treatment Targets
    David E. Cohen, M.D., M.P.H.
  • The Science of Atopic Dermatitis
    Fernanda Bellodi Schmidt, M.D.
  • Atopic Dermatitis Therapy
    Lawrence A. Schachner, M.D.
  • Atopic Dermatitis- Most Recent Developments and Emerging Treatments
    Leon H. Kircik, M.D.

The course includes the following topics:

  • Pathogenesis of Atopic Dermatitis and Treatment Targets
  • Atopic Dermatitis: Most Recent Developments and Emerging Therapeutic Options
  • PEDIATRIC PERSPECTIVE: Video and slide highlights will be produced from the Masters of Pediatric Dermatology conference for learners interested in the pediatric perspective.

Transcripts will also be provided.

Target Audience

This activity has been designed to meet the educational needs of physicians, advanced practice registered nurses and registered nurses and involved in the care of patients with atopic dermatitis.

Learning Objectives

  • Identify AD based on the evaluation of clinical characteristics specific to infants, children, adolescents, and adult patients.
  • List the pathogenic mechanisms of AD across the age spectrum, from pediatric through adult populations.
  • Review individualized treatment plans for pediatric and adult patients with moderate-to-severe AD based on current guideline recommendations for AD, the safety and efficacy of new and emerging treatment options, comorbidities, and patient quality of life.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 ANCC
  • 1.50 Participation
Course opens: 
07/31/2020
Course expires: 
07/31/2021

Fernanda Bellodi Schmidt, MD
Assistant Professor
University of Miami
Miami, FL

David E. Cohen, M.D., M.P.H.
Charles and Dorothea Harris Professor
and Vice Chairman for Clinical Affairs
Director of Allergic, Occupational and Environmental Dermatology
New York University School of Medicine Department of Dermatology
New York, NY

Leon H. Kircik M.D.
Clinical Associate
Professor of Dermatology
Indiana University School of Medicine
Mount Sinai Medical Center, New York, NY
Physicians Skin Care, PLLC
Louisville, KY

Lawrence A. Schachner, M.D.
Professor, Chair Emeritus and Stiefel Laboratories Chair
Director of the Division of Pediatric Dermatology
Department of Dermatology & Cutaneous Surgery
Professor, Department of Pediatrics
Leonard M. Miller School of Medicine
University of Miami
Miami, FL

  • For questions about the certification of this activity, please visit www.annenberg.net
  • Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and South Beach Symposium in collaboration with Postgraduate Institute for Medicine
  • This activity is supported by an independent medical education grant from LEO Pharma

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and South Beach Symposium. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Accreditation Statements

The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

1.5 contact hours may be earned for successful completion of this activity. Designated for 0.5 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.

Disclosure of Conflicts of Interest

The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The Annenberg Center for Health Sciences at Eisenhower is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

Fernanda Bellodi Schmidt, M.D. has nothing to disclose.

David E. Cohen, M.D., M.P.H.
Consulting fees from Ferndale Laboratories, Asana, Medimetriks, Leo, UCB, Cutanea, Ferrer, Celgene, Dermavant, FSJ, FIDE. (FIDE receives industry sponsorship from AbbVie, Almirall, Amgen, Bausch and Lomb, Bristol-Myers Squibb, Celgene Dermavant, Dermira, Janssen, Kyowa Hakko Kirin, LEO, Lilly, Novartis, Ortho Dermatologics, Pfizer, Sanofi Genzyme, Sun Pharma, UCB, Valeant)
Ownership Interest less than 5%: Demira, Medimetriks, Brickell Biotech, Kadmon, Evommune
Board of Directors/Ownership Interest less than 5%: Kadmon, Evommune, [Dermira-Past]

Leon H. Kircik M.D.
Consulting fees from Leo Pharma, Dermira, Eli Lilly, Abbvie, Novartis, Incyte, Dermavant, Arcutis, Ortho Dermatologics,
Grant funding from Leo Pharma, Regeneron, Eli Lilly, Abbvie, Novartis, Incyte, Dermavant, Arcutis, Ortho Dermatologics, Arena

Lawrence A. Schachner, M.D. has nothing to disclose.

Planners and Managers

Annenberg Center for the Health Sciences at Eisenhower staff involved in this activity have no relevant commercial relationships to disclose.

The South Beach Symposium planners and managers have nothing to disclose.

The PIM planners and managers have nothing to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 ANCC
  • 1.50 Participation
Please login or register to take this course.

Required Hardware/software

  • Hardware: Computer, keyboard, mouse
  • Software: WiFI access and internet